FDA Drug Class III — Least Serious

Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15

Hazard

Failed Moisture Limits: out of specification test results for water content obtained during stability testing.

Products

Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmac
Brand
Teva Pharmaceuticals USA
UPC
Lot # 3138405A, Exp 8/2017

Units Affected

2,880 cartons (30 unit dose blister pack per carton)